SBIR/STTR awards account for over $780,000,000 awarded per year by NIH alone. These are excellent sources of funding aimed at promoting R&D activities of US-based small businesses as well as collaborations with Academics. SBIR/STTRs differ from traditional NIH mechanisms in that they are highly product driven and ultimately are seeking commercialization of novel therapies, diagnostics, […]
We all had an amazing week in San Diego, seeing hundreds of new and familiar faces! FreeMind was quite pleased to give away 5 bottles of Grants Whisky this year and we look forward to helping our clients win hundreds of thousands of dollars in governments grants before the year is out. Two lucky winners: Mary […]
Every year, US-based non-dilutive sources of funding award billions of dollars towards clinical stage research in the Life Sciences. Funding is available for clinical stage funding across scientific fields including Infectious Diseases, Neurosciences, Cardiovascular, and many more. These funds come from multiple Institutes within the NIH, such as NIAID, NIAMS, NIDDK, from BARDA, and from […]
Every year, US-based non-dilutive sources of funding award billions of dollars towards pre-clinical stage research in the Life Sciences. Funding is available for pre-clinical research across scientific fields including Infectious Diseases, Oncology, Neurosciences, and many more. These funds come from Institutes within the NIH, such as NIAID, NCI, NINDS, the NSF, the DoD, and private […]
Congress: NIH Budget Will Not Be Cut Congress Inks Spending Deal That Jettisons Trump Priorities – Bloomberg News, May 1, 2017 U.S. House and Senate negotiators reached a tentative bipartisan deal on a $1.1 trillion spending bill that largely tracks with Democratic priorities and rejects most of President Donald Trump’s wish list. Overall, the compromise […]
NIH alone awards roughly $6B annually to Cancer related R&D grants and contracts. The scope of funding support covers much of the R&D cycle with an emphasis on pre-clinical work, and may cover clinical stage activities as well. In this webinar, we discuss key cancer related opportunities, mainly within the National Cancer Institute (NCI), that […]
Tyler Merkeley, CARB-X co-founder and program director for ASPR’s Biomedical Advanced Research and Development Authority, describes the drivers and next steps in creating a diverse portfolio Powered by CARB-X, one of the world’s largest public-private partnerships dedicated to accelerating development of innovative antibacterial drugs, diagnostics, and devices.
FreeMind is proud to support the upcoming Investment for Advanced Therapies event! When: May 3, 2017 Where: London, UK Investment for Advanced Therapies will be the C-Level meeting place for heavyweight investors, analysts, biotechs, venture partners and industry experts who are driving the industry forward. Don’t miss your chance to shape the future and put your […]
FreeMind is pleased to support the upcoming MedFIT event! Where: Grenoble, France When: June 28-29, 2017 A 360° approach to build innovation partnerships, source licensing deals and accelerate market access in medtech. Organised by Eurasanté and the NHL Cluster, with the support of Medicalps and Alsace BioValley, the 1st edition of MedFIT will gather […]